BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22935770)

  • 1. Applicability of a keratinocyte gene signature to predict skin sensitizing potential.
    van der Veen JW; Pronk TE; van Loveren H; Ezendam J
    Toxicol In Vitro; 2013 Feb; 27(1):314-22. PubMed ID: 22935770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the N/TERT epidermal model for skin sensitizer identification via Nrf2-Keap1-ARE pathway activation.
    Alloul-Ramdhani M; Tensen CP; El Ghalbzouri A
    Toxicol In Vitro; 2014 Aug; 28(5):982-9. PubMed ID: 24794257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2010 Sep; 29(3):171-92. PubMed ID: 20491607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression changes induced by skin sensitizers in the KeratinoSens™ cell line: Discriminating Nrf2-dependent and Nrf2-independent events.
    Emter R; van der Veen JW; Adamson G; Ezendam J; van Loveren H; Natsch A
    Toxicol In Vitro; 2013 Dec; 27(8):2225-32. PubMed ID: 24055896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency.
    Teunis M; Corsini E; Smits M; Madsen CB; Eltze T; Ezendam J; Galbiati V; Gremmer E; Krul C; Landin A; Landsiedel R; Pieters R; Rasmussen TF; Reinders J; Roggen E; Spiekstra S; Gibbs S
    Toxicol In Vitro; 2013 Apr; 27(3):1135-50. PubMed ID: 22728231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis.
    Saito K; Nukada Y; Takenouchi O; Miyazawa M; Sakaguchi H; Nishiyama N
    Toxicol In Vitro; 2013 Dec; 27(8):2213-24. PubMed ID: 23999411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GARD assay for assessment of chemical skin sensitizers.
    Johansson H; Albrekt AS; Borrebaeck CA; Lindstedt M
    Toxicol In Vitro; 2013 Apr; 27(3):1163-9. PubMed ID: 23032079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds.
    Vandebriel RJ; Pennings JL; Baken KA; Pronk TE; Boorsma A; Gottschalk R; Van Loveren H
    Toxicol Sci; 2010 Sep; 117(1):81-9. PubMed ID: 20566472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human relevance of an in vitro gene signature in HaCaT for skin sensitization.
    van der Veen JW; Hodemaekers H; Reus AA; Maas WJ; van Loveren H; Ezendam J
    Toxicol In Vitro; 2015 Feb; 29(1):81-4. PubMed ID: 25236440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GARD platform for potency assessment of skin sensitizing chemicals.
    Zeller KS; Forreryd A; Lindberg T; Gradin R; Chawade A; Lindstedt M
    ALTEX; 2017; 34(4):539-559. PubMed ID: 29156079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals.
    Natsch A; Emter R
    Toxicol Sci; 2008 Mar; 102(1):110-9. PubMed ID: 17932397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an in vitro method to estimate the sensitization induction level of contact allergens.
    Galbiati V; Papale A; Marinovich M; Gibbs S; Roggen E; Corsini E
    Toxicol Lett; 2017 Apr; 271():1-11. PubMed ID: 28189648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
    Aptula AO; Patlewicz G; Roberts DW; Schultz TW
    Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epidermal equivalent assay for identification and ranking potency of contact sensitizers.
    Gibbs S; Corsini E; Spiekstra SW; Galbiati V; Fuchs HW; Degeorge G; Troese M; Hayden P; Deng W; Roggen E
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):529-41. PubMed ID: 23876969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorescence high throughput screening method for the detection of reactive electrophiles as potential skin sensitizers.
    Avonto C; Chittiboyina AG; Rua D; Khan IA
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):177-84. PubMed ID: 26455772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro.
    Emter R; Ellis G; Natsch A
    Toxicol Appl Pharmacol; 2010 Jun; 245(3):281-90. PubMed ID: 20307559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiles and pathways in skin inflammation induced by three different sensitizers and an irritant.
    Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Yun SM; Ryu DY
    Toxicol Lett; 2009 Oct; 190(2):231-7. PubMed ID: 19647056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.